| Tempus Primary Care, Llc | |
|
4101 Balmoral Dr Sw Ste B Huntsville AL 35801-6535 | |
| (904) 994-2865 | |
| Not Available |
| Full Name | Tempus Primary Care, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 4101 Balmoral Dr Sw Ste B, Huntsville, Alabama |
| Authorized Official Name and Position | John David Nall (PRESIDENT) |
| Authorized Official Contact | 2565555555 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Tempus Primary Care, Llc 17 Legacy Oaks Pl Se Gurley AL 35748-8102 Ph: () - | Tempus Primary Care, Llc 4101 Balmoral Dr Sw Ste B Huntsville AL 35801-6535 Ph: (904) 994-2865 |
| NPI Number | 1043810195 |
|---|---|
| Provider Enumeration Date | 10/28/2020 |
| Last Update Date | 11/09/2021 |
| Medicare PECOS PAC ID | 8527457894 |
|---|---|
| Medicare Enrollment ID | O20211109000394 |
News Archive
A new study shows that juvenile delinquents sentenced to either a juvenile retreat, probation or unsupervised community service were seven times more likely to commit criminal acts as adults than youngsters from the control group who managed to avoid the juvenile justice system.
LyoTechnica, LLC has announced that it has been established to provide contract drug development services for injectable pharmaceuticals. The company and its affiliates bring over 80 years of combined experience in lyophilization and liquid dosage form development as well as over 100 years experience in commercial scale manufacturing of parenteral drugs. The company offers analytical and formulation development, manufacturing of sterile stability batches and stability testing services.
The powerful gene-editing tool, CRISPR, has revolutionized research by allowing scientists to snip and patch DNA with remarkable precision. But tracking the impact of these changes on gene function can be time-consuming. Researchers currently analyze each edit one at a time, a process that can take weeks.
Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson's disease.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043810195 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Jennifer L Ryder |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386191914 PECOS PAC ID: 7315221843 Enrollment ID: I20170301001815 |
News Archive
A new study shows that juvenile delinquents sentenced to either a juvenile retreat, probation or unsupervised community service were seven times more likely to commit criminal acts as adults than youngsters from the control group who managed to avoid the juvenile justice system.
LyoTechnica, LLC has announced that it has been established to provide contract drug development services for injectable pharmaceuticals. The company and its affiliates bring over 80 years of combined experience in lyophilization and liquid dosage form development as well as over 100 years experience in commercial scale manufacturing of parenteral drugs. The company offers analytical and formulation development, manufacturing of sterile stability batches and stability testing services.
The powerful gene-editing tool, CRISPR, has revolutionized research by allowing scientists to snip and patch DNA with remarkable precision. But tracking the impact of these changes on gene function can be time-consuming. Researchers currently analyze each edit one at a time, a process that can take weeks.
Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson's disease.
› Verified 5 days ago
| Provider Name | John D Nall |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1285029371 PECOS PAC ID: 5294088803 Enrollment ID: I20181030000027 |
News Archive
A new study shows that juvenile delinquents sentenced to either a juvenile retreat, probation or unsupervised community service were seven times more likely to commit criminal acts as adults than youngsters from the control group who managed to avoid the juvenile justice system.
LyoTechnica, LLC has announced that it has been established to provide contract drug development services for injectable pharmaceuticals. The company and its affiliates bring over 80 years of combined experience in lyophilization and liquid dosage form development as well as over 100 years experience in commercial scale manufacturing of parenteral drugs. The company offers analytical and formulation development, manufacturing of sterile stability batches and stability testing services.
The powerful gene-editing tool, CRISPR, has revolutionized research by allowing scientists to snip and patch DNA with remarkable precision. But tracking the impact of these changes on gene function can be time-consuming. Researchers currently analyze each edit one at a time, a process that can take weeks.
Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson's disease.
› Verified 5 days ago
| Provider Name | Annsley Elizabeth Noterman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1376938464 PECOS PAC ID: 6901192491 Enrollment ID: I20211203001460 |
News Archive
A new study shows that juvenile delinquents sentenced to either a juvenile retreat, probation or unsupervised community service were seven times more likely to commit criminal acts as adults than youngsters from the control group who managed to avoid the juvenile justice system.
LyoTechnica, LLC has announced that it has been established to provide contract drug development services for injectable pharmaceuticals. The company and its affiliates bring over 80 years of combined experience in lyophilization and liquid dosage form development as well as over 100 years experience in commercial scale manufacturing of parenteral drugs. The company offers analytical and formulation development, manufacturing of sterile stability batches and stability testing services.
The powerful gene-editing tool, CRISPR, has revolutionized research by allowing scientists to snip and patch DNA with remarkable precision. But tracking the impact of these changes on gene function can be time-consuming. Researchers currently analyze each edit one at a time, a process that can take weeks.
Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson's disease.
› Verified 5 days ago
News Archive
A new study shows that juvenile delinquents sentenced to either a juvenile retreat, probation or unsupervised community service were seven times more likely to commit criminal acts as adults than youngsters from the control group who managed to avoid the juvenile justice system.
LyoTechnica, LLC has announced that it has been established to provide contract drug development services for injectable pharmaceuticals. The company and its affiliates bring over 80 years of combined experience in lyophilization and liquid dosage form development as well as over 100 years experience in commercial scale manufacturing of parenteral drugs. The company offers analytical and formulation development, manufacturing of sterile stability batches and stability testing services.
The powerful gene-editing tool, CRISPR, has revolutionized research by allowing scientists to snip and patch DNA with remarkable precision. But tracking the impact of these changes on gene function can be time-consuming. Researchers currently analyze each edit one at a time, a process that can take weeks.
Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson's disease.
› Verified 5 days ago
Bptcare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 311 Longwood Dr, Sw, Huntsville, AL 35801 Phone: 256-534-5946 Fax: 256-534-3041 | |
Inspirational Counseling Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4100 Market St Ste 100, Huntsville, AL 35808 Phone: 256-210-4925 | |
Gleneagles Family Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1102 Gleneagles Dr Sw, Huntsville, AL 35801 Phone: 256-881-5880 Fax: 256-883-3280 | |
Magnolia Primary Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4245 Balmoral Dr Sw Ste 102, Huntsville, AL 35801 Phone: 256-203-6676 Fax: 833-979-0980 | |
Five Points Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 502 Pratt Ave Ne, Huntsville, AL 35801 Phone: 256-714-3363 | |
Davis Medical Group, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7850 Memorial Pkwy Sw, Huntsville, AL 35802 Phone: 256-882-0132 Fax: 256-882-1461 | |
Crestani Family Medicine, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2745 Bob Wallace Ave Sw, Suite D, Huntsville, AL 35805 Phone: 256-534-1323 Fax: 256-534-1780 |